Related references
Note: Only part of the references are listed.PSMA PET/CT with Glu-urea-Lys-(Ahx)-[68Ga(HBED-CC)] versus 3D CT volumetric lymph node assessment in recurrent prostate cancer
Frederik L. Giesel et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
[68Ga]PSMA-HBED uptake mimicking lymph node metastasis in coeliac ganglia: an important pitfall in clinical practice
Thomas Krohn et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer
Ali Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
What is the role of [11C]choline PET/CT in decision making strategy before post-operative salvage radiation therapy in prostate cancer patients?
Filippo Alongi et al.
ACTA ONCOLOGICA (2014)
Helical intensity-modulated Radiotherapy of the Pelvic Lymph Nodes with Integrated Boost to the Prostate Bed - Initial Results of the PLATIN 3 Trial
Sonja Katayama et al.
BMC CANCER (2014)
Effect on therapeutic ratio of planning a boosted radiotherapy dose to the dominant intraprostatic tumour lesion within the prostate based on multifunctional MR parameters
S. F. Riches et al.
BRITISH JOURNAL OF RADIOLOGY (2014)
[11C] Choline PET/CT Impacts Treatment Decision Making in Patients With Prostate Cancer Referred for Radiotherapy
Barbara Alicja Jereczek-Fossa et al.
CLINICAL GENITOURINARY CANCER (2014)
Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer
Ali Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Pattern of occult nodal relapse diagnosed with 18F-fluoro-choline PET/CT in prostate cancer patients with biochemical failure after prostate-only radiotherapy
Alexis Lepinoy et al.
RADIOTHERAPY AND ONCOLOGY (2014)
Comparative effectiveness of radical prostatectomy and radiotherapy in prostate cancer: observational study of mortality outcomes
Prasanna Sooriakumaran et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions
A. Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Role of choline PET/CT in guiding target volume delineation for irradiation of prostate cancer
S. M. Schwarzenboeck et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Hybrid Positron Emission Tomography-Magnetic Resonance Imaging with Gallium 68 Prostate-specific Membrane Antigen Tracer: A Next Step for Imaging of Recurrent Prostate Cancer-Preliminary Results
Matthias C. Roethke et al.
EUROPEAN UROLOGY (2013)
Combined Ultrasmall Superparamagnetic Particles of Iron Oxide-Enhanced and Diffusion-weighted Magnetic Resonance Imaging Facilitates Detection of Metastases in Normal-sized Pelvic Lymph Nodes of Patients with Bladder and Prostate Cancer
Frederic D. Birkhaeuser et al.
EUROPEAN UROLOGY (2013)
Critical Evaluation of Magnetic Resonance Imaging Targeted, Transrectal Ultrasound Guided Transperineal Fusion Biopsy for Detection of Prostate Cancer
Timur H. Kuru et al.
JOURNAL OF UROLOGY (2013)
Helical tomotherapy and intensity modulated proton therapy in the treatment of dominant intraprostatic lesion: A treament planning comparison
Francesco Fellin et al.
RADIOTHERAPY AND ONCOLOGY (2013)
Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer: Early late toxicity and 3-year clinical outcome
Valerie Fonteyne et al.
RADIOTHERAPY AND ONCOLOGY (2013)
68Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging
Matthias Eder et al.
BIOCONJUGATE CHEMISTRY (2012)
MRI-guided prostate biopsy detects clinically significant cancer: analysis of a cohort of 100 patients after previous negative TRUS biopsy
M. Roethke et al.
WORLD JOURNAL OF UROLOGY (2012)
IMPACT OF [18F]FLUORODEOXYGLUCOSE PET-CT STAGING ON TREATMENT PLANNING IN RADIOTHERAPY INCORPORATING ELECTIVE NODAL IRRADIATION FOR NON-SMALL-CELL LUNG CANCER: A PROSPECTIVE STUDY
Milena Kolodziejczyk et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
PARAMETERS FAVORABLE TO INTRAPROSTATIC RADIATION DOSE ESCALATION IN MEN WITH LOCALIZED PROSTATE CANCER
Nadine Housri et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
IMRT significantly reduces acute toxicity of whole-pelvis irradiation in patients treated with post-operative adjuvant or salvage radiotherapy after radical prostatectomy
Filippo Alongi et al.
RADIOTHERAPY AND ONCOLOGY (2009)
Helical Tomotherapy with Simultaneous Integrated Boost for High-Risk and Lymph Node-Positive Prostate Cancer: Early Report on Acute and Late Toxicity
Benedikt Engels et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2009)
Share Paper
